Journal

Research notes & comparisons.

Practical guides to reconstitution math, ester kinetics, and side-by-side compound references — every article links back to the calculators and catalog.

Subscribe via RSS
GuideSeptember 10, 2026

Boldenone Undecylenate (Equipoise): The Long Ester, Examined

What boldenone undecylenate is, why the undecylenate ester gives ~14-day kinetics, its veterinary history, and how the 250 mg/mL oil vial fits analytical research.

Read article

GuideSeptember 10, 2026

BPC-157 + TB-500 Blend: What the Fixed 5 mg : 5 mg Ratio Means in Practice

The canonical repair-pathway blend explained — why 5:5 mg, how to reconstitute a 10 mg dual-vial, per-component dosing math, and when separate vials beat a blend.

Read article

GuideSeptember 10, 2026

CJC-1295 + Ipamorelin: The Classic GH-Axis Pair, in Vial Math

Why a GHRH analog and a selective secretagogue are stacked, what each contributes at the receptor, and how the two vials' reconstitution math actually works day to day.

Read article

GuideSeptember 10, 2026

Dianabol (Methandrostenolone): The Classic Oral, Examined

What methandrostenolone is, why 17α-alkylation makes it oral, its short hours-scale half-life, and how 10 mg tablets are used as an analytical reference standard.

Read article

GuideSeptember 10, 2026

Masterol (Drostanolone Propionate): The Short-Acting DHT Depot

What drostanolone propionate is, why it never aromatizes, its ~4.5-day propionate kinetics, and why its detection window is surprisingly long for a 'short' ester.

Read article

GuideSeptember 10, 2026

Epitalon (Epithalon) Research Guide: Telomere Biology, Pineal Peptides, and a Compounding-List Removal

What Epitalon actually is — a synthetic pineal tetrapeptide studied in Russian telomerase biology — plus the July 2026 PCAC vote that removed it from the 503A list and what that means for research sourcing.

Read article

GuideSeptember 10, 2026

How to Choose a Research Peptide Supplier: Nine Checks That Actually Predict Quality

A buyer-side evaluation framework for peptide and analytical-steroid vendors — COA linkage, batch consistency, CAS discipline, cold-chain reality, and the red flags that correlate with mislabeled product.

Read article

GuideSeptember 10, 2026

How to Read a Peptide COA: A Field Guide for Researchers

Every block on a peptide certificate of analysis, what each assay actually measures, and the eight checks that separate a usable COA from a decorative one — with a worked example.

Read article

GuideSeptember 10, 2026

LGD-4033 (Ligandrol) Research Reference: The Human-Trial SARM With a Suppression Fine-Print

Ligandrol is one of few SARMs with published human-phase data — and that data is precisely what makes it a documentation-first research compound. Chemistry, trial record, and analytical specs.

Read article

GuideSeptember 10, 2026

Masteron (Methenolone Enanthate): The Mild Injectable, Examined

What methenolone enanthate is, why the DHT scaffold never aromatizes, its ~10-day depot kinetics, and how the 100 mg/mL oil vial fits comparative androgen research.

Read article

ComparisonSeptember 10, 2026

Ostarine vs RAD-140: What Preclinical Science and One Abandoned Trial Program Show

The two most-searched SARMs compared on the only axes that hold up: receptor pharmacology, published human trial data (one has them, one doesn't), and what the enobosarm program's end tells researchers.

Read article

ResearchSeptember 10, 2026

The 2026 Peptide Regulatory Timeline: Cat-2 Removals, the PCAC Votes, and What Comes Next

Month by month through 2026: the April removal of 12 peptides from the 503A Category 2 list, the July PCAC votes with exact tallies, and the pending reviews — a working tracker for research buyers.

Read article

GuideSeptember 10, 2026

RAD-140 (Testolone) for Research Reference: Chemistry, Potency Data, and What the Absence of Human Trials Means

Testolone is the highest-affinity SARM in most published receptor panels — and has zero completed human trials. What preclinical science establishes, what it cannot, and how to spec it analytically.

Read article